Insuline Medical (INSIF) 1.5500 $INSIF
Insuline Medical to Receive Funding from Israel's Chief Scientist for Use of Its Injection Site Treatment and Stabilization Technology with Long Acting Insulin
PR Newswire - Mon Mar 21, 7:00AM CDT
Insuline Medical (INSL.TA) which develops, manufactures and markets medical device products to improve the efficacy of insulin therapy, announced that it has received funding approval from Israel's Office of the Chief Scientist for development of a product to improve long acting insulin therapy.
Insulin Delivery Pipeline Review 2015 - Extensive Coverage of the Insulin Delivery Products Under Development
M2 - Fri Aug 14, 8:07AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8ffvgt/insulin_delivery) has announced the addition of the "Insulin Delivery - Pipeline Review, 2015" report to their offering. Summary This Medical Devices sector report, Insulin Delivery - Pipeline Review, 2015" provides an overview of Insulin Delivery currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Insulin Delivery pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by Our team of industry experts. Scope - The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities - The report reviews the major players involved in the development of Insulin Delivery and list all their pipeline projects - The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage - The report provides key clinical trial data of ongoing trials specific to pipeline products - Recent developments in the segment / industry Key Topics Covered: 1 List of Tables and List of Figures 2 Introduction 3 Products under Development 4 Insulin Delivery - Pipeline Products under Development by Companies 5 Insulin Delivery Companies and Product Overview 6 Insulin Delivery- Recent Developments 7 Appendix Companies Mentioned - Amrita Vishwa Vidyapeetham - Andain, Inc - AstraZeneca PLC - Becton, Dickinson and Company - Cellnovo Ltd. - CeQur SA - Companion Medical - ConvaTec Healthcare B S.a.r.l. - Dance Biopharm Inc. - Debiotech S.A. - InsuLenz - Insulet Corporation - InsuLine Medical Ltd. - LifeScan, Inc. - Medical International Technologies (Mit Canada) Inc. - MedSolve Technologies, Inc. - MicroPort Scientific Corporation - North Carolina State University - Sanofi - SFC Fluidics LLC - Spring Health Solutions Ltd. - Transdermal Specialties, Inc. - University of KwaZulu-Natal - University of Toronto - Ypsomed Holding AG For more information visit http://www.researchandmarkets.com/research/8f...n_delivery
PODD: 43.49 (-0.25), AZN: 33.56 (-0.01)
Insuline Medical Appoints Jacob Harel to its Board of Directors
PR Newswire - Thu Jan 08, 6:32AM CST
Insuline Medical (TASE: INSL), a company developing, manufacturing, and marketing medical devices to improve insulin therapy for insulin-reliant diabetics, has announced the appointment of Mr. Jacob Harel to its Board of Directors. Mr. Harel has over 27 years of experience in sales, marketing, operation and business development in senior executive positions in the pharmaceutical industry.
Insuline Medical to Receive Funding from Israel's Chief Scientist for Use of Its Injection Site Treatment and Stabilization Technology with Long Acting Insulin
PR Newswire - Mon Mar 21, 7:00AM CDT
Insuline Medical (INSL.TA) which develops, manufactures and markets medical device products to improve the efficacy of insulin therapy, announced that it has received funding approval from Israel's Office of the Chief Scientist for development of a product to improve long acting insulin therapy.
Insulin Delivery Pipeline Review 2015 - Extensive Coverage of the Insulin Delivery Products Under Development
M2 - Fri Aug 14, 8:07AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8ffvgt/insulin_delivery) has announced the addition of the "Insulin Delivery - Pipeline Review, 2015" report to their offering. Summary This Medical Devices sector report, Insulin Delivery - Pipeline Review, 2015" provides an overview of Insulin Delivery currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Insulin Delivery pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by Our team of industry experts. Scope - The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities - The report reviews the major players involved in the development of Insulin Delivery and list all their pipeline projects - The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage - The report provides key clinical trial data of ongoing trials specific to pipeline products - Recent developments in the segment / industry Key Topics Covered: 1 List of Tables and List of Figures 2 Introduction 3 Products under Development 4 Insulin Delivery - Pipeline Products under Development by Companies 5 Insulin Delivery Companies and Product Overview 6 Insulin Delivery- Recent Developments 7 Appendix Companies Mentioned - Amrita Vishwa Vidyapeetham - Andain, Inc - AstraZeneca PLC - Becton, Dickinson and Company - Cellnovo Ltd. - CeQur SA - Companion Medical - ConvaTec Healthcare B S.a.r.l. - Dance Biopharm Inc. - Debiotech S.A. - InsuLenz - Insulet Corporation - InsuLine Medical Ltd. - LifeScan, Inc. - Medical International Technologies (Mit Canada) Inc. - MedSolve Technologies, Inc. - MicroPort Scientific Corporation - North Carolina State University - Sanofi - SFC Fluidics LLC - Spring Health Solutions Ltd. - Transdermal Specialties, Inc. - University of KwaZulu-Natal - University of Toronto - Ypsomed Holding AG For more information visit http://www.researchandmarkets.com/research/8f...n_delivery
PODD: 43.49 (-0.25), AZN: 33.56 (-0.01)
Insuline Medical Appoints Jacob Harel to its Board of Directors
PR Newswire - Thu Jan 08, 6:32AM CST
Insuline Medical (TASE: INSL), a company developing, manufacturing, and marketing medical devices to improve insulin therapy for insulin-reliant diabetics, has announced the appointment of Mr. Jacob Harel to its Board of Directors. Mr. Harel has over 27 years of experience in sales, marketing, operation and business development in senior executive positions in the pharmaceutical industry.
